WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/22/2024ACC: 0001415889-24-027573
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-16K
Net shares
Net seller
$159.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
16K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−16K
Price / share
$9.97
Trade value
$159.49K
% of position
0.9%
11/20/2024
1.83M→1.81M
Total
Net shares
−16K
Net value
-$159.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2024 | F · Tax Withholding | −16K | $9.97 | $159.49K | 0.9% | 1.83M | 1.81M |
| Total | −16K | -$159.49K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned3.90K
Ordinary Shares
IndirectShares owned92.57K
Total
96.47K indirect96.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 3.90K | Indirect |
| Ordinary Shares | 92.57K | Indirect |
| Total | 96.47K | 96.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported